Muna Therapeutics
A bold vision of resilience to treat neurodegenerative diseases
Copenhagen, Denmark · $74.0M raised
- Headquarters
- Copenhagen
- Business Model
- B2B
- Website
- munatherapeutics.com
- Total Funding
- $74.0M
- Last Round
- $1.0M GrantJan 2026
- Rounds
- 3
About
Biotechnology company developing therapies to slow or stop neurodegenerative diseases including Alzheimer's and Parkinson's.
Summary
Muna Therapeutics is a Biotech company based in Copenhagen, Denmark. It has raised $74.0M in total across 3 rounds, most recently a $1.0M Grant round in Jan 2026. Investors include Novo Holdings A/S, Sofinnova Partners and LSP Dementia Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company